Gale For Nurses
- 1st occurrence - 3-day suspension
- 2nd occurrence - 5-day suspension
- 3rd occurrence - 7-day suspension
- 4th occurrence - Termination and ineligible for rehire
Facility COVID FAQs
Nurse COVID FAQs
- Pre-screening of caregivers, patients and visitors prior to entry into patient care areas. (Visitor restrictions in patient care areas).
- Proper use of isolation for patients with confirmed or suspected COVID-19 infection.
- Masks for patients with respiratory symptoms.
- Reinforcing infection prevention protocols and effective environmental cleaning.
- CDC recommends patients with suspected or confirmed diagnosis of COVID-19 should wear a face mask, if tolerated.
- Healthcare providers providing direct care to a patient with suspected or confirmed diagnosis of COVID-19 should follow facility protocols, which will involve proper full PPE for respiratory isolation.
- Other healthcare providers may also be required to wear PPE. Again, follow the facility infection control protocol.
- Stay home when you are sick.
- Follow strict adherence to local rules related to sheltering in place. Go out into the public only when necessary. Avoid close contact with people who are sick.
- Practice social-distancing. If in a small crowd of people, stay at least 6 ft away from another individual.
- Avoid touching your face, eyes, nose, and mouth.
- Cough into your elbow, or cover your cough or sneeze with a tissue, and throw the tissue in the trash immediately.
- Wash your hands often—especially after touching public areas, such as doors, handles, shopping carts, elevator buttons, etc., or use an antibacterial gel consisting of at least 60% alcohol. Use either soap and water, or alcohol-based hand gel for at least 20 seconds.
- Clean and disinfect frequently touched objects and surfaces using a disinfecting household cleaning spray or wipe.
- Fever has been resolved without the use of fever-reducing medications; and
- Improvement in respiratory symptoms (e.g., cough, shortness of breath); and
- You receive Negative results of an FDA Emergency Use Authorized molecular assay for COVID-19 from at least two consecutive nasopharyngeal swab specimens collected ≥24 hours apart (total of two negative specimens).